The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
On the Nature of the Multivalency Effect: A Thermodynamic Model
Abstract
A quantitative model is proposed for the analysis of the thermodynamic parameters of multivalent interactions in dilute solutions or with immobilized multimeric receptor. The model takes into account all bound species and describes multivalent binding via two microscopic binding energies corresponding to inter- and intramolecular interactions (Delta G(o)inter and Delta G(o)intra), the relative contributions of which depend on the distribution of complexes with different numbers of occupied binding sites. The third component of the overall free energy, which we call the "avidity entropy" term, is a function of the degeneracy of bound states, Omega(i), which is calculated on the basis of the topology of interaction and the distribution of all bound species. This term grows rapidly with the number of receptor sites and ligand multivalency, it always favors binding, and explains why multivalency can overcome the loss of conformational entropy when ligands displayed at the ends of long tethers are bound. The microscopic parameters and may be determined from the observed binding energies for a set of oligovalent ligands by nonlinear fitting with the theoretical model. Here binding data obtained from two series of oligovalent carbohydrate inhibitors for Shiga-like toxins were used to verify the theory. The decavalent and octavalent inhibitors exhibit subnanomolar activity and are the most active soluble inhibitors yet seen that block Shiga-like toxin binding to its native receptor. The theory developed here in conjunction with our protocol for the optimization of tether length provides a predictive approach to design and maximize the avidity of multivalent ligands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mammen, M., Choi, S.-K., & Whitesides, G. M. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981102)37:20<2754::aid-anie2754>3.0.co;2-3 · Cited by 4,110
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Lundquist, J. J., & Toone, E. J. (2002) · Chemical Reviews · doi:10.1021/cr000418f · Cited by 1,576
On the attribution and additivity of binding energies
Jencks, W. P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4046 · Cited by 912
Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands
Kitov, P. I., Sadowska, J. M., Mulvey, G., Armstrong, G. D., Ling, H., Pannu, N. S., Read, R. J., & Bundle, D. R. (2000) · Nature · doi:10.1038/35001095 · Cited by 869
Self-citationStructure of the Shiga-like Toxin I B-Pentamer Complexed with an Analogue of Its Receptor Gb3,
Ling, H., Boodhoo, A., Hazes, B., Cummings, M. D., Armstrong, G. D., Brunton, J. L., & Read, R. J. (1998) · Biochemistry · doi:10.1021/bi971806n · Cited by 438
Structure and function of the pentraxins
Gewurz, H., Zhang, X.-H., & Lint, T. F. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80029-8 · Cited by 328
On the Meaning of Affinity: Cluster Glycoside Effects and Concanavalin A
Dimick, S. M., Powell, S. C., McMahon, S. A., Moothoo, D. N., Naismith, J. H., & Toone, E. J. (1999) · Journal of the American Chemical Society · doi:10.1021/ja991729e · Cited by 240
How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis
Glynne, R., Akkaraju, S., Healy, J. I., Rayner, J., Goodnow, C. C., & Mack, D. H. (2000) · Nature · doi:10.1038/35001102 · Cited by 210
Safe as mother's milk: Carbohydrates as future anti-adhesion drugs for bacterial diseases
Sharon, N., & Ofek, I. (2000) · Glycoconjugate Journal · doi:10.1023/a:1011091029973 · Cited by 193
Cited by
Binding Mechanisms in Supramolecular Complexes
Schneider, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802947 · Cited by 1,145
From carbohydrate leads to glycomimetic drugs
Ernst, B., & Magnani, J. L. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2852 · Cited by 820
Antibody Structure and Function: The Basis for Engineering Therapeutics
Chiu, M. L., Goulet, D. R., Teplyakov, A., & Gilliland, G. L. (2019) · Antibodies · doi:10.3390/antib8040055 · Cited by 638
Multivalency and Cooperativity in Supramolecular Chemistry
Badjić, J. D., Nelson, A., Cantrill, S. J., Turnbull, W. B., & Stoddart, J. F. (2005) · Accounts of Chemical Research · doi:10.1021/ar040223k · Cited by 635
The Binding Avidity of a Nanoparticle-Based Multivalent Targeted Drug Delivery Platform
Hong, S., Leroueil, P. R., Majoros, I. J., Orr, B. G., Baker, J. R., & Banaszak Holl, M. M. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.11.015 · Cited by 586
Glycomimetics versus Multivalent Glycoconjugates for the Design of High Affinity Lectin Ligands
Cecioni, S., Imberty, A., & Vidal, S. (2015) · Chemical Reviews · doi:10.1021/cr500303t · Cited by 544
Multivalency in supramolecular chemistry and nanofabrication
Mulder, A., Huskens, J., & Reinhoudt, D. N. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b413971b · Cited by 467
Multivalent Effects of RGD Peptides Obtained by Nanoparticle Display
Montet, X., Funovics, M., Montet-Abou, K., Weissleder, R., & Josephson, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060515m · Cited by 388
Designing the nanoparticle–biomolecule interface for “targeting and therapeutic delivery”
Mahon, E., Salvati, A., Baldelli Bombelli, F., Lynch, I., & Dawson, K. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.009 · Cited by 385
Designing super selectivity in multivalent nano-particle binding
Martinez-Veracoechea, F. J., & Frenkel, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105351108 · Cited by 346
Cell surface biology mediated by low affinity multivalent protein–glycan interactions
Collins, B. E., & Paulson, J. C. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.10.004 · Cited by 335
Johansson, E. M. V., Crusz, S. A., Kolomiets, E., Buts, L., Kadam, R. U., Cacciarini, M., Bartels, K.-M., Diggle, S. P., Cámara, M., Williams, P., et al. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.10.009 · Cited by 263
Calixarenes: from biomimetic receptors to multivalent ligands for biomolecular recognition
Sansone, F., Baldini, L., Casnati, A., & Ungaro, R. (2010) · New Journal of Chemistry · doi:10.1039/c0nj00285b · Cited by 167
Drug delivery using multifunctional dendrimers and hyperbranched polymers
Paleos, C. M., Tsiourvas, D., Sideratou, Z., & Tziveleka, L.-A. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.534981 · Cited by 156
Quantitative fragmentomics allow affinity mapping of interactomes
Gogl, G., Zambo, B., Kostmann, C., Cousido-Siah, A., Morlet, B., Durbesson, F., Negroni, L., Eberling, P., Jané, P., Nominé, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33018-0 · Cited by 51
Warnet, X. L., Bakke Krog, H., Sevillano‐Quispe, O. G., Poulsen, H., & Kjaergaard, M. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14842 · Cited by 50
Metadata
- Authors
- Kitov, P. I., & Bundle, D. R.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2003-12-01
- Volume
- 125
- Issue
- 52
- Pages
- 16271-16284
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2021755139
- Cited by
- 445
- References
- 14
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.